Authors
Lorenzo Azzalini, Gurpreet S Johal, Usman Baber, Jeffrey Bander, Pedro R Moreno, Lucas Bazi, Vishal Kapur, Nitin Barman, Annapoorna S Kini, Samin K Sharma
Publication date
2021/1/1
Journal
Catheterization and Cardiovascular Interventions
Volume
97
Issue
1
Pages
E26-E33
Publisher
John Wiley & Sons, Inc.
Description
Objectives
We aimed to evaluate the early and one‐year outcomes of Impella‐supported high‐risk nonemergent percutaneous coronary intervention (PCI).
Background
The evidence for the use of mechanical circulatory support (MCS) devices in high‐risk nonemergent PCI is limited and nonconclusive.
Methods
We performed a single‐center retrospective study including all patients who underwent high‐risk nonemergent PCI supported by Impella 2.5/CP at our institution between January 2009 and June 2018. This patient population was propensity score matched with subjects undergoing PCI with no MCS. The primary endpoint was major adverse cardiac events (MACE: all‐cause death, myocardial infarction [MI], and target lesion revascularization) at one‐year follow‐up.
Results
Two‐hundred fifty patients undergoing Impella‐supported nonemergent PCI were matched to 250 controls. The two groups were …
Scholar articles
L Azzalini, GS Johal, U Baber, J Bander, PR Moreno… - Catheterization and Cardiovascular Interventions, 2021